Parkinson

Parkinson's Disease and Related Disorders Part I

Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab)

This volume provides a complete guide to advancements made in the understanding of Parkinson’s disease and related neurodegenerative disorders. From information on early research conducted in the 1960’s, to modern clinical views of these diseases, this handbook will give clinicians and neuroscientists a state-of-the-art reference that presents critical appraisals on recent developments in the study of these disorders.

As the world population in developed countries ages, these observations are particularly relevant. Dramatic data on the genetic causes of dominant and recessive forms of hereditary Parkinson’s disease are presented, as well as new knowledge on the differences in the intricate circuitry of basal ganglia in healthy individuals and those afflicted with Parkinson’s.

Clinicians will find this to be a great platform on which to base ongoing investigative approaches and research.

Audience
Neurologists and neuroscience research workers

,

Published: June 2007

Imprint: Elsevier

ISBN: 978-0-444-51900-9

Reviews

  • -------------------------------------------------------------------------------------
    The Volume I on Parkinson’s Disease in the Handbook of Clinical Neurology series covers, in fact, the scientific background, general aspects of Parkinson’s Disease, clinical aspects and aetiology; it also covers a group of disorders that constitute the commonest of neurodegenerative diseases and one that is assuming ever greater importance with the ageing of the population in developed countries. The coverage reflects the dramatic advances in understanding of the biochemical background of Parkinsonism and the resulting developments in the pharmacological management of the disease.

    This volume gives a comprehensive account of the subject for both clinical neurologists and those researching in the neurosciences.

    In summary, this book demystifies, enlightens, and educates; an outstanding accomplishment; the style is uniform and the text reader-friendly punctuated with useful tables, and the clinical descriptions and practical approach to patient management are what make this an exceptional text. General neurologists, movement disorders fellows, and internists will all find this book an excellent source.

    Reviewed by Mohammad Zeibo, Department of Neurology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71103, USA

    30 July 2007
    ---------------------------------------------------------------------------------------

Contents

  • Section 1: Scientific foundation

    Anatomy and physiology of the basal ganglia: relevance to parkinson’s disease and related disorders. Functional neurochemistry of the basal ganglia. Dopamine receptor pharmacology.

    Section 2: General aspects of Parkinson's disease

    History of Parkinson’s disease. Epidemiology of Parkinson’s disease. Neurochemistry of the basal ganglia in Parkinson’s disease. The neuropathology of parkinsonism. Imaging Parkinson’s disease. Parkinson’s disease: animal models.

    Section 3: Clinical aspects

    Scales to measure parkinsonism. Motor symptoms in Parkinson’s disease. Autonomic dysfunction in Parkinson’s disease. Sleep in Parkinson syndromes. Sensory symptoms in Parkinson’s disease. Speech disorders in Parkinson’s disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment. Clinical features, pathophysiology and treatment of dementia associated with Parkinson’s disease. Disorders of mood and affect in Parkinson’s disease. Neurobehavioral disorders in Parkinson’s disease. Early detection of Parkinson’s disease.

    Section 4: Etiology

    Mitochondria in the etiology of Parkinson’s disease. Iron as a trigger of neurodegeneration in Parkinson’s disease. Oxidative stress and Parkinson’s disease. Neurotrophic factors and Parkinson’s disease. Neuroinflammation and Parkinson’s disease. Excitotoxicity. Protein handling dysfunction in Parkinson’s disease. Programmed cell death in Parkinson’s disease.

Advertisement

advert image